SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-18-339756
Filing Date
2018-11-30
Accepted
2018-11-30 16:41:06
Documents
8
Effectiveness Date
2018-11-30

Document Format Files

Seq Description Document Type Size
1 FORM S-8 d660611ds8.htm S-8 64296
2 EX-5.1 d660611dex51.htm EX-5.1 6270
3 EX-23.2 d660611dex232.htm EX-23.2 1479
4 EX-23.3 d660611dex233.htm EX-23.3 2006
5 EX-99.1 d660611dex991.htm EX-99.1 192437
6 EX-99.2 d660611dex992.htm EX-99.2 35515
7 EX-99.3 d660611dex993.htm EX-99.3 36422
8 GRAPHIC g660611dsp002.jpg GRAPHIC 2443
  Complete submission text file 0001193125-18-339756.txt   343141
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-228623 | Film No.: 181211631
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1